NCT04606875

Correlation of Campbell Score With Suicidal Ideation

Assessment of Campbell Score as a Means of Predicting Suicidal Ideation High Risk Patients

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 30 (estimated)
• Sponsor: Therapeutic Solutions International · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The Campbell Score is a blood based means of assessing molecules believed to be associated with suicidal ideation and in some cases successful suicide. The current clinical trial will assess the Campbell Score in 3 groups: Group 1: 10 patients with no personal or family psychiatric history and no suicide attempts. Group 2: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported low acquired capability for suicide (Acquired Capability for Suicide Scale \<20). Group 3: 10 patients with suicidal ideation (Hamilton Depression Rating Scale suicide item \>2) and reported high acquired capability for suicide (Acquired Capability for Suicide Scale \>60). The goal of the study is to confirm efficacy of Campbell Score in identifying patients with high suicidal ideation potential.

Conditions

• Suicidal Ideation

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Campbell Score	The Campbell Score is a blood based assessment of inflammatory and immunologically associated markers that is currently in development as a means of predicting suicidal ideations.

Timeline

• Start date: 2020-11-05
• Primary completion: 2021-01-13
• Completion: 2021-02-13
• First posted: 2020-10-28
• Last updated: 2020-10-28

Locations

1 site across 1 country: United States